The objective of this webinar organised by NATA and supported by an unrestricted educational grant from Pharmacosmos is to provide an overview of the available evidence and practical recommendations on the management of perioperative iron deficiency anaemia.
The live educational event held on September 28, 2020 was accredited by the European Accreditation Council for Continuing Medical Education (EACCME) with 1 European CME credit. The EACCME is an institution of the European Union of Medical Specialists (UEMS),
This on-demand version has not been submitted for CME accreditation.


Welcome and introduction
Jens Meier, Linz, Austria
Preoperative intravenous iron to treat anaemia before major abdominal surgery – the PREVENTT trial
Andrew A. Klein, Cambridge, UK
Management of iron deficiency anaemia in the perioperative period – why and when?
Donat R. Spahn, Zurich, Switzerland
Optimising patient safety – management of infusion reactions to intravenous iron
Wendy Lim, Hamilton, ON, Canada
Interactive panel discussion
Jean-François Hardy – Andrew A. Klein Wendy Lim Jens Meier Donat R. Spahn

Erratum (Prof. Spahn’s presentation): In the PREVENTT trial, patients assigned to the intravenous iron group received a single 1000 mg dose of ferric carboxymaltose, not 20 mg/kg BW.